Stigma, misinformation and ‘a slap in the face’:ADHD in pharmacy


Pharmacists have a key role to play in helping their neurodiverse patients—but when it comes to patients with ADHD, barriers and roadblocks abound. Megan Haggan reports In December 2024, the Albanese government released its response to the Senate Inquiry into Attention Deficit Hyperactive Disorder (ADHD)—supporting only one of the subsequent report’s 15 recommendations. The accepted

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Lilly drops push for Ebglyss PBS listing
Next ‘They’ve probably leapfrogged us by a decade’